Nanoceria As a Possible Agent for the Management of COVID-19
Overview
Authors
Affiliations
The COVID-19 pandemic has emerged as an unprecedented global healthcare emergency and has devastated the global economy. The SARS-CoV-2 virus replicates in the host cells and is seemingly much more virulent compared to other flu viruses, as well as the SARS-CoV-1. The respiratory complications of the disease include acute respiratory distress syndrome (ARDS), cytokine storm, systemic inflammation, and pulmonary fibrosis. Nanoceria (NC) is a versatile rare earth nanoparticle with remarkable catalase and superoxide dismutase mimetic redox regenerative properties. Interestingly, NC possesses promising anti-inflammatory, antioxidant and anti-fibrotic properties, making it an attractive tool to fight against the SARS-CoV-2 as well as the associated systemic complications. Until now, there is no clinically approved vaccine or drug for the treatment of COVID-19, and the conquest to find a novel therapy for this global havoc is being undertaken at a warlike pace. Herein, based on preclinical evidence, we hypothesize that NC owing to its unique pharmacological properties, might be an attractive preclinical candidate to win the battle over COVID-19. Further, it may be used as a prevention or treatment strategy in combination with other drugs.
Inhalable nanocatalytic therapeutics for viral pneumonia.
Peng W, Tai W, Li B, Wang H, Wang T, Guo S Nat Mater. 2024; .
PMID: 39592721 DOI: 10.1038/s41563-024-02041-5.
Nucleic acid-based nanotherapeutics for treating sepsis and associated organ injuries.
Yu H, Liu F, Chung Y, Alalaiwe A, Sung C, Fang J Theranostics. 2024; 14(11):4411-4437.
PMID: 39113804 PMC: 11303080. DOI: 10.7150/thno.98487.
Komiyama M Sci Technol Adv Mater. 2023; 24(1):2250705.
PMID: 37701758 PMC: 10494760. DOI: 10.1080/14686996.2023.2250705.
Khurana A, Allawadhi P, Singh V, Khurana I, Yadav P, Sathua K J Drug Deliv Sci Technol. 2023; 86:104663.
PMID: 37362903 PMC: 10249347. DOI: 10.1016/j.jddst.2023.104663.
Nano-based techniques: A revolutionary approach to prevent covid-19 and enhancing human awareness.
Annamalai A, Karuppaiya V, Ezhumalai D, Cheruparambath P, Balakrishnan K, Venkatesan A J Drug Deliv Sci Technol. 2023; 86:104567.
PMID: 37313114 PMC: 10183109. DOI: 10.1016/j.jddst.2023.104567.